Status:
COMPLETED
Bulimia Nervosa: A Biobehavioral Study (The Eating Disorder Study)
Lead Sponsor:
Drexel University
Collaborating Sponsors:
Columbia University
The Miriam Hospital
Conditions:
Bulimia Nervosa
Eligibility:
FEMALE
18-45 years
Brief Summary
The purpose of this study is to examine biological (e.g., energy expenditure, neuroendocrine and appetitive hormones)and behavioral (e.g., binge eating and purging) correlates of weight suppression an...
Detailed Description
Bulimia nervosa (BN) is a debilitating psychiatric disorder that primarily affects young women. Empirically supported treatments for BN have been identified but less than half of treated individuals a...
Eligibility Criteria
Inclusion
- Diagnosis of bulimia nervosa according to the proposed DSM-V criteria
- Either currently receiving eating disorder treatment or actively seeking treatment
- BMI above 18.5 and below 30
- Not experiencing any signs of menopause
- Medically stable as determined by each site's study physician
Exclusion
- Change in pharmacological treatment over past 4 weeks
- Currently taking atypical antipsychotic medications
- History of anorexia nervosa within the past year
- Pregnancy
- Currently taking medications that could alter hormone levels or metabolism
- Disorders affecting metabolism or hormone levels
- Non-removal metallic object
- Co-occurring severe mental illness
- At risk for suicide
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01830374
Start Date
August 1 2012
End Date
May 31 2018
Last Update
July 30 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10032
2
Drexel University
Philadelphia, Pennsylvania, United States, 19104